Latest news
Lobeglitazone Shows Long-Term Renal Safety in T2DM, Including CKD Patients : Study - Medical DialoguesMedical Dialogues · Sat, 08 Aug 2026 04:00:10 GMTTirzepatide Reduces risk of Heart Attack and hospitalisation due to Infection in Type 2 Diabetes: Study - Medical DialoguesMedical Dialogues · Sat, 08 Aug 2026 03:30:41 GMTPolyendocrine Metabolic Ovarian Syndrome May Independently Predict Cardiovascular Disease: Lancet - Medical DialoguesMedical Dialogues · Thu, 06 Aug 2026 05:00:55 GMTGenetic test results alone may not predict severe epilepsy outcomes - Dravet Syndrome NewsDravet Syndrome News · Tue, 28 Jul 2026 07:00:00 GMT